BAK Stock Overview
Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Braskem S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R$8.89 |
52 Week High | R$12.67 |
52 Week Low | R$6.30 |
Beta | 1.01 |
1 Month Change | -14.27% |
3 Month Change | 19.01% |
1 Year Change | 18.85% |
3 Year Change | -56.72% |
5 Year Change | -62.80% |
Change since IPO | 71.46% |
Recent News & Updates
Braskem: A Rising Odds For ADNOC Deal, Though Declining Risk-Reward (Rating Downgrade)
Apr 05Braskem: Mounting Troubles Impacting Financial Performance
Jan 25Braskem: Special Situations Trade With 100% Upside Potential
Dec 12Recent updates
Braskem: A Rising Odds For ADNOC Deal, Though Declining Risk-Reward (Rating Downgrade)
Apr 05Braskem: Mounting Troubles Impacting Financial Performance
Jan 25Braskem: Special Situations Trade With 100% Upside Potential
Dec 12Braskem: Glad I Sold After A 27.8% Negative RoR
Nov 09Braskem: A Speculative Bet On A Cycle Downturn
Aug 27Braskem: It's Time To Be Careful After The M&A (Rating Downgrade)
Aug 04Braskem: 22% RoR Since March, Still A 'Buy' After Q1 2023
May 24Braskem: Second Look At This International Petrochemical Player After A ~30% Drop
Dec 26Braskem S.A. GAAP EPS of $1.73 beats by $1.70, revenue of $4.83B beats by $780M
Nov 10Braskem Buoyed By A Buyout Offer
Oct 13Braskem: Time To Look Beyond The EU/North America?
Aug 03Braskem S.A.: Undervalued Moneymaker With Game-Changing Potential
May 18Braskem: Growth Stock Moving In Line With ESG Commitments
Feb 22Record Resin Prices Leaving Braskem In Great Shape
Aug 25Braskem expects to spend 9B reais to address Alagoas geological damage
Dec 31Braskem: A Justified Valuation Discount
Dec 15Mexico cuts off gas supply to Braskem plant in escalating dispute
Dec 03Braskem S.A. beats on revenue
Nov 11Shareholder Returns
BAK | US Chemicals | US Market | |
---|---|---|---|
7D | 3.7% | 0.3% | 1.2% |
1Y | 18.9% | 8.9% | 24.7% |
Return vs Industry: BAK exceeded the US Chemicals industry which returned 8.9% over the past year.
Return vs Market: BAK underperformed the US Market which returned 24.7% over the past year.
Price Volatility
BAK volatility | |
---|---|
BAK Average Weekly Movement | 7.9% |
Chemicals Industry Average Movement | 5.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BAK has not had significant price volatility in the past 3 months.
Volatility Over Time: BAK's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1972 | 8,569 | Roberto Bischoff | www.braskem.com.br |
Braskem S.A., together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.
Braskem S.A. Fundamentals Summary
BAK fundamental statistics | |
---|---|
Market cap | US$3.45b |
Earnings (TTM) | -US$892.66m |
Revenue (TTM) | US$13.76b |
0.3x
P/S Ratio-3.9x
P/E RatioIs BAK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BAK income statement (TTM) | |
---|---|
Revenue | R$70.57b |
Cost of Revenue | R$67.55b |
Gross Profit | R$3.02b |
Other Expenses | R$7.60b |
Earnings | -R$4.58b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
Earnings per share (EPS) | -5.75 |
Gross Margin | 4.28% |
Net Profit Margin | -6.49% |
Debt/Equity Ratio | 1,707.1% |
How did BAK perform over the long term?
See historical performance and comparison